Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2019

01-01-2019 | Original Article

Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis

Authors: David Chirio, Marion Le Marechal, Pamela Moceri, Arnaud de la Chapelle, Sylvie Chaillou-Optiz, Anaïs Mothes, Cédric Foucault, Laurence Maulin, Chirine Parsaï, Pierre-Marie Roger, Elisa Demonchy

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2019

Login to get access

Abstract

We aimed to identify factors associated with unfavorable outcome in patients treated for infective endocarditis (IE), with a focus on departure from European guidelines. We conducted a retrospective audit of all adult patients treated for endocarditis during a 1-year period across a regional network of nine care centers in the south-east of France. Medical records were reviewed regarding patient and infection characteristics, antibiotic therapy, outcome, and compliance to the European Society of Cardiology guidelines. Antibiotic treatment appropriateness was evaluated regarding molecule, dosage, and duration, according to guidelines. Primary endpoint was the assessment of factors associated with unfavorable outcome, defined as in-hospital mortality or IE relapse at 1-year follow-up. Secondary endpoints were intensive care admission, iatrogenic events, and nosocomial infections that occurred during hospital stay. One hundred patients were included. Median age was 71 years old. Twenty-two patients died and IE relapse occurred in two patients, representing 24 patients with unfavorable outcome. Overall, antibiotic treatment was deemed appropriate in 28 cases. Thirty-three patients required intensive care, 34 iatrogenic events were found, including 19 acute kidney injuries, and 13 nosocomial infections occurred during care. Using a logistic regression, factors associated with unfavorable outcome were admission in the intensive care unit (adjusted odd ratio 7.26 [1.8–29.28]; p = 0.005), new-onset nosocomial infection (adjusted odd ratio 8.83 [1.42–54.6]; p = 0.019), and age > 71 years old (adjusted odd ratio 11.2 [2.76–46.17]; p < 0.001). Departure from guidelines was frequent but not related to unfavorable outcome in our study. Only intensive care, age, and nosocomial infections were associated with mortality and relapse. Iatrogenic events were numerous, with no impact on outcome.
Literature
1.
go back to reference Abdulhak AAB, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA et al (2014) Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9:131–143CrossRef Abdulhak AAB, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA et al (2014) Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9:131–143CrossRef
2.
go back to reference Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana J et al (2017) The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep 19:1–10CrossRef Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana J et al (2017) The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep 19:1–10CrossRef
3.
go back to reference Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F et al (2017) Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther 7:27–35CrossRefPubMedPubMedCentral Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F et al (2017) Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther 7:27–35CrossRefPubMedPubMedCentral
4.
go back to reference Chirillo F, Scotton P, Rocco F, Rigoli R, Borsatto F, Pedrocco A et al (2013) Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 112:1171–1176CrossRefPubMed Chirillo F, Scotton P, Rocco F, Rigoli R, Borsatto F, Pedrocco A et al (2013) Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 112:1171–1176CrossRefPubMed
5.
go back to reference Lagier J-C, Aubry C, Delord M, Michelet P, Tissot-Dupont H, Million M et al (2017) From expert protocols to standardized management of infectious diseases. Clin Infect Dis 65:S12–S19CrossRefPubMed Lagier J-C, Aubry C, Delord M, Michelet P, Tissot-Dupont H, Million M et al (2017) From expert protocols to standardized management of infectious diseases. Clin Infect Dis 65:S12–S19CrossRefPubMed
6.
go back to reference Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30:2369–2413CrossRefPubMed Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30:2369–2413CrossRefPubMed
7.
go back to reference Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36:3075–3128CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36:3075–3128CrossRefPubMed
8.
go back to reference Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G et al (2017) International experts’ practice in the antibiotic therapy of infective endocarditis is not following the guidelines. Clin Microbiol Infect 23:736–739CrossRefPubMed Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G et al (2017) International experts’ practice in the antibiotic therapy of infective endocarditis is not following the guidelines. Clin Microbiol Infect 23:736–739CrossRefPubMed
9.
go back to reference Béraud G, Pulcini C, Paño-Pardo JR, Hoen B, Beovic B, Nathwani D (2016) How do physicians cope with controversial topics in existing guidelines for the management of infective endocarditis? Results of an international survey. Clin Microbiol Infect 22:163–170CrossRefPubMed Béraud G, Pulcini C, Paño-Pardo JR, Hoen B, Beovic B, Nathwani D (2016) How do physicians cope with controversial topics in existing guidelines for the management of infective endocarditis? Results of an international survey. Clin Microbiol Infect 22:163–170CrossRefPubMed
10.
go back to reference Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A et al (2015) Trends in infective endocarditis: incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 65:2070–2076CrossRefPubMed Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A et al (2015) Trends in infective endocarditis: incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 65:2070–2076CrossRefPubMed
11.
go back to reference Gonzalez de Molina M, Fernández-Guerrero JC, Azpitarte J (2002) Infectious endocarditis: degree of discordance between clinical guidelines recommendations and clinical practice. Rev Esp Cardiol 55:793–800CrossRefPubMed Gonzalez de Molina M, Fernández-Guerrero JC, Azpitarte J (2002) Infectious endocarditis: degree of discordance between clinical guidelines recommendations and clinical practice. Rev Esp Cardiol 55:793–800CrossRefPubMed
12.
go back to reference Demonchy E, Dellamonica P, Roger PM, Bernard E, Cua E, Pulcini C (2011) Audit of antibiotic therapy used in 66 cases of endocarditis. Méd Mal Infect 41:602–607CrossRefPubMed Demonchy E, Dellamonica P, Roger PM, Bernard E, Cua E, Pulcini C (2011) Audit of antibiotic therapy used in 66 cases of endocarditis. Méd Mal Infect 41:602–607CrossRefPubMed
13.
go back to reference Di Mauro M, Dato GMA, Barili F, Gelsomino S, Santè P, Corte AD et al (2017) A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis: the EndoSCORE. Int J Cardiol 241:97–102CrossRefPubMed Di Mauro M, Dato GMA, Barili F, Gelsomino S, Santè P, Corte AD et al (2017) A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis: the EndoSCORE. Int J Cardiol 241:97–102CrossRefPubMed
14.
go back to reference Subbaraju P, Rai S, Morakhia J, Midha G, Kamath A, Saravu K (2018) Clinical – microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in Southern India. Indian Heart J 70:259–265CrossRefPubMed Subbaraju P, Rai S, Morakhia J, Midha G, Kamath A, Saravu K (2018) Clinical – microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in Southern India. Indian Heart J 70:259–265CrossRefPubMed
15.
go back to reference Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V et al (2016) Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37:840–848CrossRefPubMed Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V et al (2016) Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37:840–848CrossRefPubMed
16.
go back to reference Ibrahim SL, Zhang L, Brady TM, Hsu AJ, Cosgrove SE, Tamma PD (2015) Low-dose gentamicin for uncomplicated Enterococcus faecalis bacteremia may be nephrotoxic in children. Clin Infect Dis 61:1119–1124CrossRefPubMedPubMedCentral Ibrahim SL, Zhang L, Brady TM, Hsu AJ, Cosgrove SE, Tamma PD (2015) Low-dose gentamicin for uncomplicated Enterococcus faecalis bacteremia may be nephrotoxic in children. Clin Infect Dis 61:1119–1124CrossRefPubMedPubMedCentral
17.
go back to reference Ritchie BM, Hirning BA, Stevens CA, Cohen SA, DeGrado JR (2017) Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center. J Chemother 29:292–298CrossRefPubMed Ritchie BM, Hirning BA, Stevens CA, Cohen SA, DeGrado JR (2017) Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center. J Chemother 29:292–298CrossRefPubMed
Metadata
Title
Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis
Authors
David Chirio
Marion Le Marechal
Pamela Moceri
Arnaud de la Chapelle
Sylvie Chaillou-Optiz
Anaïs Mothes
Cédric Foucault
Laurence Maulin
Chirine Parsaï
Pierre-Marie Roger
Elisa Demonchy
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3401-9

Other articles of this Issue 1/2019

European Journal of Clinical Microbiology & Infectious Diseases 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.